Connection

Alessandra Vultaggio to Asthma

Back to Details
This is a "connection" page, showing publications Alessandra Vultaggio has written about Asthma.
Alessandra Vultaggio
Connection Strength
0.453
Asthma
  1. COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey. Allergy. 2021 03; 76(3):871-874.
    View in: PubMed
    Score: 0.223
  2. Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity. Respir Med. 2021 01; 176:106261.
    View in: PubMed
    Score: 0.057
  3. Omalizumab dampens type 2 inflammation in a group of long-term treated asthma patients and detaches IgE from FceRI. Eur J Immunol. 2018 12; 48(12):2005-2014.
    View in: PubMed
    Score: 0.049
  4. The use of intravenous versus subcutaneous monoclonal antibodies in the treatment of severe asthma: a review. Respir Res. 2018 Aug 16; 19(1):154.
    View in: PubMed
    Score: 0.048
  5. Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question? Respir Res. 2018 06 08; 19(1):113.
    View in: PubMed
    Score: 0.048
  6. The TLR7 ligand 9-benzyl-2-butoxy-8-hydroxy adenine inhibits IL-17 response by eliciting IL-10 and IL-10-inducing cytokines. J Immunol. 2011 Apr 15; 186(8):4707-15.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.